Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8+ T cell activation in the presence of adjuvant temozolomide-Reference-Cited by-同舟云学术

Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8+ T cell activation in the presence of adjuvant temozolomide

Published:2018-01-29 Issue:4 Volume:7 Page:e1412901
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Pellegatta Serena¹,Eoli Marica¹,Cuccarini Valeria²^ORCID,Anghileri Elena¹,Pollo Bianca³,Pessina Sara¹,Frigerio Simona⁴,Servida Maura¹,Cuppini Lucia¹,Antozzi Carlo⁵,Cuzzubbo Stefania¹,Corbetta Cristina¹,Paterra Rosina¹,Acerbi Francesco⁶,Ferroli Paolo⁶,DiMeco Francesco⁷,Fariselli Laura⁸,Parati Eugenio A.⁴,Bruzzone Maria Grazia²,Finocchiaro Gaetano¹^ORCID

Affiliation:

1. Unit of Molecular Neuro-Oncology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy

2. Unit of Neuro-Radiology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy

3. Unit of Neuropathology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy

4. Cell Therapy Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy

5. Unit of Neuro-Immunology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy

6. Unit of Neurosurgery 2, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy

7. Unit of Neurosurgery 1, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy

8. Unit of Radiotherapy, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2017.1412901

Reference37 articles.

1. Clinical use of dendritic cells for cancer therapy

2. Perspectives for immunotherapy in glioblastoma treatment

3. Cancer immunotherapy – revisited

4. Immunological aspects of cancer chemotherapy

5. The secret ally: immunostimulation by anticancer drugs

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy for children with malignant brain tumors;Russian Journal of Immunology;2024-08-06

2. Response assessment of GBM during immunotherapy by delayed contrast treatment response assessment maps;Frontiers in Neurology;2024-04-08

3. The need for paradigm shift: prognostic significance and implications of standard therapy-related systemic immunosuppression in glioblastoma for immunotherapy and oncolytic virotherapy;Frontiers in Immunology;2024-02-08

4. GARNL3 identified as a crucial target for overcoming temozolomide resistance in EGFRvIII-positive glioblastoma;American Journal of Translational Research;2024

5. Glioblastoma Immunotherapy: A Systematic Review of the Present Strategies and Prospects for Advancements;International Journal of Molecular Sciences;2023-10-10